Literature DB >> 18258983

Premature ovarian failure and its consequences: vasomotor symptoms, sexuality, and fertility.

Leslie R Schover1.   

Abstract

Premature ovarian failure is a common consequence of systemic treatment for premenopausal breast cancer. Vasomotor symptoms and sexual dysfunction occur frequently in women who have an abrupt menopause from chemotherapy or ovarian suppression. However, current fertility may be impaired even in women who are menstruating after chemotherapy, and survivors are at high risk for permanent ovarian failure at a young age. Hot flashes can be managed with venlaxafine, gabapentin, or-potentially-stress management. Providing advice on treating vaginal dryness and brief sexual counseling can often alleviate sexual dysfunction. Options for fertility preservation remain limited but are improving rapidly. Distress about interrupted childbearing has a long-term impact on the quality of life.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18258983     DOI: 10.1200/JCO.2007.14.1655

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  63 in total

1.  Climacteric Complaints after Breast Cancer - Is HRT an Option?

Authors:  Christian F Singer
Journal:  Breast Care (Basel)       Date:  2008-06-20       Impact factor: 2.860

Review 2.  Health-related quality of life in ovarian cancer patients and its impact on clinical management.

Authors:  Dana M Chase; Lari Wenzel
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2011-08       Impact factor: 2.217

3.  Sisters Peer Counseling in Reproductive Issues After Treatment (SPIRIT): a peer counseling program to improve reproductive health among African American breast cancer survivors.

Authors:  Leslie R Schover; Michelle M Rhodes; George Baum; Jennifer Harned Adams; Rosell Jenkins; Pamela Lewis; Karen Eubanks Jackson
Journal:  Cancer       Date:  2011-04-14       Impact factor: 6.860

4.  Premature menopause in young breast cancer: effects on quality of life and treatment interventions.

Authors:  Shoshana M Rosenberg; Ann H Partridge
Journal:  J Thorac Dis       Date:  2013-06       Impact factor: 2.895

5.  Effect of leuprolide acetate on ovarian function after cyclophosphamide-doxorubicin-based chemotherapy in premenopausal patients with breast cancer: results from a phase II randomized trial.

Authors:  Guiping Song; Hui Gao; Zhixiang Yuan
Journal:  Med Oncol       Date:  2013-08-01       Impact factor: 3.064

6.  Cancer survivorship and the young breast cancer patient: addressing the important issues.

Authors:  Ann H Partridge
Journal:  Oncologist       Date:  2013

Review 7.  Unique aspects of caring for young breast cancer patients.

Authors:  Raina M Ferzoco; Kathryn J Ruddy
Journal:  Curr Oncol Rep       Date:  2015-02       Impact factor: 5.075

Review 8.  The time is now for a new approach to primary ovarian insufficiency.

Authors:  Amber R Cooper; Valerie L Baker; Evelina W Sterling; Mary E Ryan; Teresa K Woodruff; Lawrence M Nelson
Journal:  Fertil Steril       Date:  2010-02-26       Impact factor: 7.329

Review 9.  Management of fertility in patients treated for Hodgkin's lymphoma.

Authors:  Stephanie Harel; Christophe Fermé; Catherine Poirot
Journal:  Haematologica       Date:  2011-08-09       Impact factor: 9.941

10.  Impact of breast cancer on anti-mullerian hormone levels in young women.

Authors:  H I Su; S W Flatt; L Natarajan; A DeMichele; A Z Steiner
Journal:  Breast Cancer Res Treat       Date:  2012-12-09       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.